Historical record - last NADAC effective date: 2/18/2015
Product Information
GENGRAF 100 MG/ML SOLUTION is a generic product labeled by AbbVie Inc., priced at $2.9312 per ML under NDC 00074726950. Its NADAC has been published 90 times since Nov 28, 2013.
FDA first approved this application on Mar 3, 2000.
Strength
100 mg/mL
Manufacturer
AbbVie Inc.NDC
00074726950
Classification
Generic
Dosage Form
SOLUTION
Route
ORAL
Effective Date
2/18/2015
Active Ingredients
CYCLOSPORINEApproval Type
Generic (ANDA)
FDA Application
ANDA065025FDA Approved
3/3/2000
On Market Since
5/25/2010
Pharmacological Classes
Price Statistics
The NADAC for GENGRAF 100 MG/ML SOLUTION has been published 90 times since Nov 28, 2013, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $2.9312 per ML |
|---|---|
| All-time high | $4.6427 (Feb 11, 2015) |
| All-time low | $2.8272 (Apr 23, 2014) |
| Median price | $2.9794 |
| Average price | $3.3275 |
| Largest weekly change | +54.8% (Nov 19, 2014) |
| Weeks tracked | 90 |
| Tracking since | Nov 28, 2013 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
N/A
5Y
N/A
All
-1.6%
Last surveyed Aug 12, 2015 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 31% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
AbbVie Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Cyclosporine market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Calcineurin Inhibitor Immunosuppressant class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of GENGRAF 100 MG/ML SOLUTION?
The current National Average Drug Acquisition Cost (NADAC) for GENGRAF 100 MG/ML SOLUTION, manufactured by AbbVie Inc., is $2.9312 per ML (NDC 00074726950), effective Aug 12, 2015.
How has the price of GENGRAF 100 MG/ML SOLUTION changed over time?
Over the history we have for it, the NADAC for GENGRAF 100 MG/ML SOLUTION has held within roughly two percent of its current level. It has been tracked across 90 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for GENGRAF 100 MG/ML SOLUTION?
Since Nov 28, 2013, the NADAC for GENGRAF 100 MG/ML SOLUTION has ranged from a low of $2.8272 (Apr 23, 2014) to a high of $4.6427 (Feb 11, 2015), with a median of $2.9794 per ML.
Are there cheaper alternatives to GENGRAF 100 MG/ML SOLUTION?
Yes. 1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, CYCLOSPORINE MODIFIED 100 MG/ML, is $2.0368 per ML — about 31% below GENGRAF 100 MG/ML SOLUTION.
Who manufactures GENGRAF 100 MG/ML SOLUTION?
GENGRAF 100 MG/ML SOLUTION (NDC 00074726950) is labeled by AbbVie Inc., and CMS classifies it as a generic product.